InvestorsHub Logo
Followers 16
Posts 1771
Boards Moderated 0
Alias Born 09/05/2017

Re: None

Tuesday, 03/15/2022 12:40:30 PM

Tuesday, March 15, 2022 12:40:30 PM

Post# of 462060
Missling's mistake again....

Why does he lead a PR with biomarker crap and Phase 2 headlines no one gives a crap about. That's not investable.

Lead with all the efficacy data since that's what is ultimately important.

Efficacy is in the bullet points why not the headline. Seems dumb, but then again I think Missling is dumb. Not book smart dumb, but street smart dumb.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News